Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1117 of 5804
-
Iron infusion trial aims to boost exercise in lung disease patients
Disease control Recruiting nowPulmonary hypertension (PH) is a condition characterized by elevated blood pressure in the pulmonary arteries. This leads to symptoms such as shortness of breath and a significantly reduced exercise capacity, resulting in a very poor quality of life. Currently, treatment options …
Phase: PHASE4 • Sponsor: Ziekenhuis Oost-Limburg • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Spinal device offers new hope for women with chronic pelvic pain
Symptom relief Recruiting nowSacral neuromodulation (SNM) is a safe, effective, and minimally invasive FDA approved treatment for urinary and fecal incontinence, urinary frequency, urgency, and urinary retention. In this study we are assessing the effectiveness of sacral neuromodulation in women with sufferi…
Phase: NA • Sponsor: Corewell Health East • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New study brings opioid addiction treatment to community centers
Disease control Not yet recruitingA multisite effectiveness-implementation study will be conducted in four sites to evaluate interventions to improve engagement and retention in MOUD with buprenorphine treatment persons with Opioid Use Disorder (OUD) in urban neighborhoods with high overdose rates. The investigat…
Phase: NA • Sponsor: Howard University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New injection plus chemo-radiation targets tough head and neck tumors
Disease control Recruiting nowThis global, open-label, single arm, phase 1b study aims to learn more about whether a treatment called JNJ-90301900 is safe and effective when injected directly into tumors, along with standard chemotherapy and radiation therapy, for participants with head and neck squamous cell…
Phase: PHASE1 • Sponsor: Johnson & Johnson Enterprise Innovation Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can red light slow vision loss in dry AMD?
Disease control Not yet recruitingThis prospective, double-blind, randomized controlled trial aims to evaluate the efficacy and safety of repeated low-level red-light (RLRL) therapy in patients with dry age-related macular degeneration (AMD). The primary objective is to assess the effect of RLRL therapy on visual…
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Quercetin: a new hope for lung fibrosis?
Disease control Recruiting nowFibrotic interstitial lung diseases (F-ILDs), including both idiopathic pulmonary fibrosis (IPF) and non-IPF, are chronic and progressive lung diseases characterized by excessive scarring of lung tissue, leading to declining lung function, respiratory failure, and high mortality,…
Phase: NA • Sponsor: Katerina M. Antoniou • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can two weeks of intensive therapy tame PTSD?
Symptom relief Recruiting nowThe objective of the study is to obtain knowledge about the treatment of patients who are offered intensive trauma treatment at Nydalen DPS (NDPS) and Søndre Oslo DPS (SODPS). The treatment takes place on an outpatient basis over two weeks. Up to 42 patients will be recruited. Th…
Phase: NA • Sponsor: Oslo University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New drug aims to tame Graves' disease Long-Term
Disease control ENROLLING_BY_INVITATIONThis is a long-term extension study that will rollover participants completing feeder studies IMVT-1402-2502 (NCT06727604) or IMVT-1402-2503 (NCT07018323) to evaluate the efficacy and safety of IMVT-1402 in adult participants with GD. Eligible participants will be assigned to 1 o…
Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a gut bacteria byproduct tame MS?
Disease control Recruiting nowThis study, iPROACT-MS, is part of the iPROACT group of clinical trials aiming to investigate the effects of oral supplementation with indole-3-propionic acid (IPA) in humans. IPA is naturally produced as a gut bacterial metabolite with the amino acid tryptophan as substrate. The…
Phase: NA • Sponsor: Glostrup University Hospital, Copenhagen • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New nasal spray aims to zap migraines fast
Symptom relief Recruiting nowThe purpose of this study is to learn about the efficacy and safety of PRT-064040 Nasal Spray versus placebo in the acute treatment of moderate or severe migraine.
Phase: PHASE2 • Sponsor: Sichuan Purity Pharmaceutical Technology Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New mRNA shot aims to calm stubborn autoimmune diseases
Disease control Not yet recruitingThe exact etiology and pathogenesis of immune related diseases (such as autoimmune hepatitis, systemic lupus erythematosus, etc.) have not been fully elucidated, and are generally believed to be the result of multiple factors such as genetics, environment, and immune regulation a…
Phase: EARLY_PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Social connection as medicine: a brain-training trial for gaming addiction
Disease control Recruiting nowInternet Gaming Disorder (IGD) involves impaired cognitive control linked to reduced social reward and dACC-DLPFC brain circuit dysfunction. Enhancing social reward may restore this circuit and improve symptoms. This study uses psychological interventions and neuroimaging to expl…
Phase: NA • Sponsor: The First Affiliated Hospital of Bengbu Medical University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
AI model could predict prostate cancer spread before surgery
Knowledge-focused Recruiting nowThe pathological-omics and imaging-omics in this study are combined to construct an artificial intelligence (AI) model that can predict whether high-risk prostate cancer patients may have lymph node metastasis. The model determines whether the patient has lymph node metastasis ba…
Sponsor: Anhui Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
MRNA vaccine takes on Hard-to-Treat cancers
Disease control Not yet recruitingCancer-associated fibroblasts (CAFs), as core regulators within the tumor microenvironment, significantly impede the intratumoral penetration of therapeutic agents and suppress the effective infiltration and activation of immune cells by constructing elaborate physical and functi…
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Probiotic LP-LDL® shows promise for diabetes and prediabetes management
Disease control Not yet recruitingThis randomized, double-blind, placebo-controlled clinical trial investigates the effects of the probiotic LP-LDL® (Lactobacillus plantarum ECGC 13110402) on lipid metabolism, glycemic control, inflammatory biomarkers, and cognitive function in adults with prediabetes, type 1 dia…
Phase: NA • Sponsor: Aalborg University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo aims to stall aggressive lung cancer
Disease control Not yet recruitingTo evaluate the efficacy and safety of liposome irinotecan combined with platinum and immune checkpoint inhibitor combined with antirotinib maintenance therapy after first-line induction
Phase: PHASE2 • Sponsor: China Medical University, China • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a good bacteria on your scalp regrow hair?
Disease control Recruiting nowThis is a single-center, randomized, double-blind, placebo-controlled clinical trial designed to evaluate whether topical application of Lactobacillus reuteri can safely and effectively treat androgenetic alopecia. The study is based on the concept that balancing the scalp's micr…
Phase: PHASE2 • Sponsor: Shenzhen People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New combo shows promise for rare blood cancer
Disease control Not yet recruitingThis is a multicenter, randomized, Phase 2 clinical trial designed to evaluate the efficacy and safety of golidocitinib combined with the P-GemOx (pegaspargase + gemcitabine + oxaliplatin) regimen plus PD-1 inhibitor, compared with P-GemOx plus PD-1 inhibitor alone, in participan…
Phase: PHASE2 • Sponsor: WEI XU • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Herbal granules may knock out cold symptoms in three days — a rigorous trial puts them to the test
Disease control CompletedThe goal of this clinical trial is to learn if drug Jinhua Qinggan Granules (JHQG) works to treat acute upper respiratory tract infection in adults. It will also learn about the safety of drug JHQG. The main questions it aims to answer is: • Following three days of treatment, th…
Phase: PHASE3 • Sponsor: University of Karachi • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Which diabetes pill is better for your heart? huge study aims to find out
Disease control OngoingInvestigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how…
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC